5
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Comprehensive Metabolomic and Lipidomic Profiling of Human Kidney Tissue: A Platform Comparison.

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Metabolite profiling of tissue samples is a promising approach for the characterization of cancer pathways and tumor classification based on metabolic features. Here, we present an analytical method for nontargeted metabolomics of kidney tissue. Capitalizing on different chemical properties of metabolites allowed us to extract a broad range of molecules covering small polar molecules and less polar lipid classes that were analyzed by LC-QTOF-MS after HILIC and RP chromatographic separation, respectively. More than 1000 features could be reproducibly extracted and analyzed (CV < 30%) in porcine and human kidney tissue, which were used as surrogate matrices for method development. To further assess assay performance, cross-validation of the nontargeted metabolomics platform to a targeted metabolomics approach was carried out. Strikingly, from 102 metabolites that could be detected on both platforms, the majority (>90%) revealed Spearman's correlation coefficients ≥0.3, indicating that quantitative results from the nontargeted assay are largely comparable to data derived from classical targeted assays. Finally, as proof of concept, the method was applied to human kidney tissue where a clear differentiation between kidney cancer and nontumorous material could be demonstrated on the basis of unsupervised statistical analysis.

          Related collections

          Author and article information

          Journal
          J. Proteome Res.
          Journal of proteome research
          American Chemical Society (ACS)
          1535-3907
          1535-3893
          February 03 2017
          : 16
          : 2
          Affiliations
          [1 ] Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology , 70376 Stuttgart, Germany.
          [2 ] University of Tübingen , 72074 Tübingen, Germany.
          [3 ] Department of Urology, University Hospital Tübingen , 72076 Tübingen, Germany.
          [4 ] Biocrates Life Sciences AG , 6020 Innsbruck, Austria.
          [5 ] Institute of Pathology and Neuropathology, University Hospital Tübingen , 72076 Tübingen, Germany.
          [6 ] Department of Clinical Pharmacology, University Hospital Tübingen , 72076 Tübingen, Germany.
          [7 ] Department of Pharmacy and Biochemistry, University of Tübingen , 72076 Tübingen, Germany.
          Article
          10.1021/acs.jproteome.6b00875
          27992229
          a8049003-d3bb-4096-bdcf-6fc15dbbf154
          History

          nontargeted metabolomics,metabolomics,lipidomics,kidney cancer,clear cell renal cell carcinoma (ccRCC),Q-TOF,LC−MS,tissue metabolomics,targeted metabolomics,platform comparison

          Comments

          Comment on this article